Dunkirk’s state-of-the-art facility is expected to play a significant role in the production of a new cancer-fighting drug developed by ImmunityBio Inc. On Tuesday, the company announced in a news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback